About

Medical isotopes save lives.

Nuclear Medicine departments at hospitals and cancer treatment centres use radioisotopes for both diagnosis of disease (such as cancer & cardiovascular disease) as well as therapy for some forms of cancer.  Radioisotopes are an unstable form of an element that emits radiation to transform into a more stable form.  For therapy, the isotope is part of a drug that seeks diseased cells, typically cancers.  The radiation emitted by the isotope can then destroy the cells with considerable focus to limit other cell damage.

Copper 67 (Cu-67) is an emerging therapy medical isotope for new cancer treatments. Cu-67 is an ideal radiotherapy medical isotope similar to yttrium-90 (Y-90), iodine-131 (I-131) and lutetium-177 (Lu-177) medical isotopes that are already in use for immunology.  However, production of these other isotopes (Y-90, I-131 and Lu-177) relies on aging nuclear research reactors and processing facilities, resulting in uncertain availability and high replacement costs.

Through cutting-edge diagnostic technology, isotopes (Technetium -99m – Tc-99m) are used to identify internal ailments and allow medical professionals to quickly and accurately treat patients. Previously, the production of these medical isotopes occurred only at a small number of nuclear facilities, which created harmful waste and came with a long list of security and supply concerns.

Canadian Isotope Innovations (CIIC) is the difference. Using an -novel process, we produce a critical solution to the world’s medical isotope shortage which is clean and reliable. Our proven products help preserve our health, while not compromising the Earth. Additionally, our production and supply is guaranteed; something that current nuclear reactor-based facilities cannot assure.

Our goal at CIIC is the production of safe, pure medical isotopes produced in a direct and reliable manner. We are the first producer of reactor-free medical isotopes on a commercial scale, providing a solution to a worldwide shortage.

Our dependable product and supply chain allows physicians to help patients with the care they need. Through entrepreneurial innovation and advanced technology, our process is clean, safe, and renewable. Using proven technology and led by a team of industry experts we provide a clean solution to a critical issue in the radiopharmaceutical industry. We are here to ensure people receive the care they need, without the consequences of fission-based isotope production. Protecting health, while producing safe and pure isotopes reliably.

Career Postings

We are not currently seeking to add any positions to our team. Please check back in the future.

Our Team

We are a team of dedicated experts committed to innovating the radiopharmaceutical industry by producing clean, pure medical isotopes using unique linear accelerator technology.

Mark de Jong, CTO of Canadian Isotope Innovations.

Mark de Jong

CTO

Prior to joining CII, Dr. de Jong was the Chief Medical Isotope Officer at Canadian Light Source Inc., heading up the CLS Medical Isotope Project to develop pilot production facility to produce Mo­99 via electron linear accelerators. Before that, he held various positions at Canadian… More...

Doug Ullrich, VP Engineering of Canadian Isotope Innovations.

Doug Ullrich

VP Engineering

Doug Ullrich is a mechanical engineer with specialization throughout the nuclear industry. He graduated from the University of Alberta in 1990 with a BSc. in Mechanical Engineering and is a professional engineer registered with the Association of Professional Engineers and Geoscientists of… More...

Lidia Matei, Chemist-Regulatory Affairs Manager of Canadian Isotope Innovations.

Lidia Matei

Chemist-Regulatory Affairs Manager

With over 10 years of experience in radiochemistry research and production of radiopharmaceuticals, Dr. Matei makes a great addition to the CII team. Prior to joining our team, Dr. Matei acted as a Radiochemist in the field of cyclotron produced radioisotopes. During her tenure at Best… More...

Hao Zhang, Lead Engineer, Operation & Control Systems of Canadian Isotope Innovations.

Hao Zhang

Lead Engineer, Operation & Control Systems

Hao Zhang received his Bachelor’s degree in Industrial Automation from Northwestern Polytechnical University in China ​in 1995, and a Masters of Applied Science in Electronic System Engineering from the University of Regina in 2004. Hao is a professional engineer registered with the… More...

James dela Cruz, Engineering Physicist/Analyst of Canadian Isotope Innovations.

James dela Cruz

Engineering Physicist/Analyst

James dela Cruz graduated with a B.Eng. in Engineering Physics from the University of Saskatchewan in 2014 and has continued his education in courses Accelerators for Medical Applications organized by the CERN Accelerator School in Europe. He began working at the Canadian Light Source… More...

Our Partners

Canadian Light Source

Canadian Light Source

The Canadian Light Source is a national research facility, one of the largest science projects in our country’s history, and the brightest light in Canada—millions of times brighter than even the sun—used by scientists from around the world in ground-breaking health, environmental,… More...